Matches in Wikidata for { <http://www.wikidata.org/entity/Q98950318> ?p ?o ?g. }
- Q98950318 description "2020 nî lūn-bûn" @default.
- Q98950318 description "2020年の論文" @default.
- Q98950318 description "2020年学术文章" @default.
- Q98950318 description "2020年学术文章" @default.
- Q98950318 description "2020年学术文章" @default.
- Q98950318 description "2020年学术文章" @default.
- Q98950318 description "2020年学术文章" @default.
- Q98950318 description "2020年学术文章" @default.
- Q98950318 description "2020年學術文章" @default.
- Q98950318 description "2020年學術文章" @default.
- Q98950318 description "2020年學術文章" @default.
- Q98950318 description "2020年學術文章" @default.
- Q98950318 description "2020年學術文章" @default.
- Q98950318 description "2020년 논문" @default.
- Q98950318 description "article científic" @default.
- Q98950318 description "article scientific" @default.
- Q98950318 description "article scientifique" @default.
- Q98950318 description "articol științific" @default.
- Q98950318 description "articolo scientifico" @default.
- Q98950318 description "artigo científico" @default.
- Q98950318 description "artigo científico" @default.
- Q98950318 description "artigo científico" @default.
- Q98950318 description "artikel ilmiah" @default.
- Q98950318 description "artikull shkencor" @default.
- Q98950318 description "artikulong pang-agham" @default.
- Q98950318 description "artykuł naukowy" @default.
- Q98950318 description "artículo científico publicado en 2020" @default.
- Q98950318 description "artículu científicu" @default.
- Q98950318 description "bilimsel makale" @default.
- Q98950318 description "bài báo khoa học" @default.
- Q98950318 description "naučni članak" @default.
- Q98950318 description "scienca artikolo" @default.
- Q98950318 description "scientific article published in September 2020" @default.
- Q98950318 description "scientific article published in September 2020" @default.
- Q98950318 description "scientific article published on 01 September 2020" @default.
- Q98950318 description "teaduslik artikkel" @default.
- Q98950318 description "tieteellinen artikkeli" @default.
- Q98950318 description "tudományos cikk" @default.
- Q98950318 description "vedecký článok" @default.
- Q98950318 description "vetenskaplig artikel" @default.
- Q98950318 description "videnskabelig artikel udgivet september 2020" @default.
- Q98950318 description "vitenskapelig artikkel" @default.
- Q98950318 description "vitskapeleg artikkel" @default.
- Q98950318 description "vědecký článek" @default.
- Q98950318 description "wetenschappelijk artikel" @default.
- Q98950318 description "wissenschaftlicher Artikel" @default.
- Q98950318 description "επιστημονικό άρθρο" @default.
- Q98950318 description "мақолаи илмӣ" @default.
- Q98950318 description "наукова стаття, опублікована у вересні 2020" @default.
- Q98950318 description "научна статия" @default.
- Q98950318 description "научная статья" @default.
- Q98950318 description "научни чланак" @default.
- Q98950318 description "научни чланак" @default.
- Q98950318 description "מאמר מדעי" @default.
- Q98950318 description "مقالة علمية نشرت في سبتمبر 2020" @default.
- Q98950318 description "সেপ্টেম্বর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q98950318 description "บทความทางวิทยาศาสตร์" @default.
- Q98950318 description "სამეცნიერო სტატია" @default.
- Q98950318 name "Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia" @default.
- Q98950318 name "Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia" @default.
- Q98950318 type Item @default.
- Q98950318 label "Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia" @default.
- Q98950318 label "Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia" @default.
- Q98950318 prefLabel "Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia" @default.
- Q98950318 prefLabel "Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia" @default.
- Q98950318 P1433 Q98950318-079B8B54-7926-4184-A36D-1FDDB38693BF @default.
- Q98950318 P1476 Q98950318-7097F31A-5A4E-482E-AACC-3892DF44BBEE @default.
- Q98950318 P2093 Q98950318-19AA8040-A277-46C6-ACB0-D3BDD05988FC @default.
- Q98950318 P2093 Q98950318-2B37187B-B96D-462D-8A7E-AA5F94C1A530 @default.
- Q98950318 P2093 Q98950318-44BF92C6-C88B-4B2B-B17E-1C3BB8DB8DA6 @default.
- Q98950318 P2093 Q98950318-4D4388CD-A1ED-4E87-8006-0FD5C6C828FC @default.
- Q98950318 P2093 Q98950318-4ED18437-F9EB-41B7-99A7-42E85FCF263E @default.
- Q98950318 P2093 Q98950318-532B17F0-AF58-4AFD-AC53-F1AFD9789654 @default.
- Q98950318 P2093 Q98950318-5D614853-8148-488D-A84A-39959314DA8C @default.
- Q98950318 P2093 Q98950318-8365F275-2A07-4ACE-8AC0-F2274FFCAE95 @default.
- Q98950318 P2093 Q98950318-9213C1C0-3069-4B1B-9CB5-1C559CB02AB1 @default.
- Q98950318 P2093 Q98950318-AD6A0327-F232-4B9A-8B50-B7EB39762B6B @default.
- Q98950318 P2093 Q98950318-CCD8BC3B-A3C3-406F-9041-23B0876757AB @default.
- Q98950318 P2093 Q98950318-E2EFD8F9-6B5B-486F-904D-957FDD202E8E @default.
- Q98950318 P304 Q98950318-DB3A54CC-2B6D-4E28-A67B-39695979A38A @default.
- Q98950318 P31 Q98950318-7797609B-A53F-45D6-B63A-74A037F968A1 @default.
- Q98950318 P356 Q98950318-6AEF0463-E4A9-4589-B33E-290A2782CA48 @default.
- Q98950318 P433 Q98950318-2A2CCB64-7380-4745-86F4-2B1852260355 @default.
- Q98950318 P478 Q98950318-42155CB4-D0BB-413B-AD40-693DE8059E4F @default.
- Q98950318 P50 Q98950318-1719BFEC-C3CF-44E3-856F-B61C86E37F92 @default.
- Q98950318 P50 Q98950318-CCE1035F-E5D3-4974-9745-24B4D134C1DC @default.
- Q98950318 P577 Q98950318-0ED9EA7F-BDC9-4573-B424-B8BEA01E4799 @default.
- Q98950318 P698 Q98950318-4F8789EE-7E5D-43F9-AC75-BAE62EC10138 @default.
- Q98950318 P921 Q98950318-F42FD52E-5E9C-4C4D-AE9F-27DE5E636444 @default.
- Q98950318 P932 Q98950318-3973AEBA-8F27-49D9-A3CD-15402AD709BF @default.
- Q98950318 P356 BLOODADVANCES.2020002003 @default.
- Q98950318 P698 32886753 @default.
- Q98950318 P1433 Q84365144 @default.
- Q98950318 P1476 "Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia" @default.
- Q98950318 P2093 "Franz Woltering" @default.
- Q98950318 P2093 "Grant Langdon" @default.
- Q98950318 P2093 "Isidro Jarque" @default.
- Q98950318 P2093 "James B Bussel" @default.
- Q98950318 P2093 "Juan Ke" @default.
- Q98950318 P2093 "Maciej Kaźmierczak" @default.